MM
UTHR icon

MQS Management’s United Therapeutics UTHR Stock Holding History

MQS Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-884
Closed -$273K – 665
2025
Q1 		$273K Buy
+884
New +$303K 0.16% 295
2024
Q1 		– Sell
-1,424
Closed -$313K – 676
2023
Q4 		$313K Buy
+1,424
New +$328K 0.17% 256
2023
Q2 		– Sell
-1,018
Closed -$228K – 606
2023
Q1 		$228K Buy
+1,018
New +$251K 0.15% 315
2022
Q2 		– Sell
-1,417
Closed -$254K – 562
2022
Q1 		$254K Buy
+1,417
New +$270K 0.21% 242

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

MQS Management's UTHR Position: Q2 2025 in Review

MQS Management sold out of United Therapeutics (UTHR) in Q2 2025, closing a stake of 884 shares — an estimated $273K sold.

MQS Management first reported a position in UTHR in Q1 2022 and held it in 4 quarters. The position peaked at $313K in Q4 2023. 671 funds tracked by Wall St. Rank hold UTHR as of Q2 2025.

  • MQS Management reported no remaining United Therapeutics position as of Q2 2025 after selling out during the quarter.
  • MQS Management sold 884 United Therapeutics shares in Q2 2025, an estimated $273K.
  • MQS Management first reported a position in United Therapeutics in Q1 2022 and held it in 4 quarters.
  • MQS Management's United Therapeutics position peaked at $313K in Q4 2023.
  • 671 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2025.

Based on MQS Management's 13F filing for Q2 2025, filed 31 Jul 2025.